Drug Discovery World speaks to key players in the cell and gene therapy sector to learn about the opportunities and challenges in this promising but difficult treatment area.      Developers of cell and gene therapies (CGTs) have had a difficult few years. Despite the undoubted promise of exciting new technologies in this area to treat and even provide lasting […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!